Louay Almidani, MD, MSc; Rhonda Miller, MS; Varshini Varadaraj, MD, MPH; et al.
JAMA Ophthalmol. 2024;142(4):283-291. doi:10.1001/jamaophthalmol.2023.6943
This cross-sectional study evaluates associations between vision impairment and psychosocial outcomes in US adults.
Nathan Dhablania, MS; Mina Torres, MS; Bruce Burkemper, MPH, PhD; et al.
JAMA Ophthalmol. 2024;142(4):292-298. doi:10.1001/jamaophthalmol.2023.6781
This cross-sectional study investigates the burden of uncorrected refractive error and unmet refractive need in African American individuals.
-
Invited Commentary
Toward Eliminating Visual Impairment Due to Refractive Error
Brian L. VanderBeek, MD, MPH, MSCE
JAMA Ophthalmol
Marco Nassisi, MD, PhD; Giulia Coarelli, MD, PhD; Benoit Blanchard, BSc; et al.
JAMA Ophthalmol. 2024;142(4):301-308. doi:10.1001/jamaophthalmol.2024.0001
This study describes baseline ophthalmological biomarkers in spinocerebellar ataxia type 7 carriers included in the Integrated Functional Evaluation of the Cerebellum (CERMOI) cross-sectional study.
Kyoko Ohno-Matsui, MD, PhD; Tae Igarashi-Yokoi, MD, PhD; Takeshi Azuma, MD; et al.
open access
JAMA Ophthalmol. 2024;142(4):310-319. doi:10.1001/jamaophthalmol.2024.0002
This case series examines the orientation and density of scleral collagen fibers found on polarization-sensitive optical coherence tomography (PS-OCT) of highly myopic eyes with and without dome-shaped macula.
-
Invited Commentary
Decoding Scleral Structures With Polarized Light
Clement K. Chan, MD; Martha Henao, MD
JAMA Ophthalmol
Andrew Mihalache, MD(C); Ryan S. Huang, MD(C); Marko M. Popovic, MD, MPH; et al.
free access
JAMA Ophthalmol. 2024;142(4):321-326. doi:10.1001/jamaophthalmol.2024.0017
This study evaluates the performance of the novel release of an artificial intelligence chatbot that is capable of processing imaging data.
Aaron S. Coyner, PhD; Tom Murickan, MD; Minn A. Oh, PhD; et al.
free access
JAMA Ophthalmol. 2024;142(4):327-335. doi:10.1001/jamaophthalmol.2024.0045
This diagnostic study evaluates how well autonomous artificial intelligence鈥揵ased retinopathy of prematurity screening can detect more-than-mild and type 1 retinopathy of prematurity.
Rongmei Peng, MD; Ying Jie, MD; Qin Long, MD; et al.
JAMA Ophthalmol. 2024;142(4):337-343. doi:10.1001/jamaophthalmol.2024.0101
This randomized clinical trial investigates the safety and effectiveness of a water-free cyclosporine ophthalmic solution, 0.1%, for dry eye disease.
-
Invited Commentary
Unraveling the Potential of Water-Free Cyclosporine in Dry Eye Disease
Khushali Shah, MD, MPH; Michelle K. Rhee, MD
JAMA Ophthalmol
Tiarnan D. L. Keenan, BM BCh, PhD; Clare Bailey, MD; Maria Abraham, ScM; et al.
JAMA Ophthalmol. 2024;142(4):345-355. doi:10.1001/jamaophthalmol.2024.0118
This nonrandomized controlled trial investigates the safety and efficacy of oral minocycline in the treatment of geographic atrophy in age-related macular degeneration.
Rishabh K. Singh, MD; Yan Zhao, MSc; Tobias Elze, PhD; et al.
JAMA Ophthalmol. 2024;142(4):356-363. doi:10.1001/jamaophthalmol.2024.0151
This post hoc analysis of the Ocular Hypertension Treatment Study assesses whether a polygenic risk score improves prediction of primary open-angle glaucoma onset in patients with ocular hypertension.
-
Invited Commentary
The Role of Polygenic Risk Scores in Glaucoma Management
Fei Li, MD, PhD; Xiulan Zhang, MD, PhD
JAMA Ophthalmol
Loka Thangamathesvaran, MD; Jun Kong, MD, PhD; Susan B. Bressler, MD; et al.
free access
JAMA Ophthalmol. 2024;142(4):365-370. doi:10.1001/jamaophthalmol.2024.0530
This case series describes 3 initially culture-negative cases of acute, severe, posterior-segment intraocular inflammation events occurring within the same month following faricimab intravitreal injections at a single institution.